This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Crescendo Biologics Limited. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Jayesh Majithiya: Innovator in Antibody Technology
Introduction
Jayesh Majithiya is a prominent inventor based in Cambridge, GB. He has made significant contributions to the field of biotechnology, particularly in the development of innovative therapeutic agents. His work focuses on single domain antibodies, which have the potential to revolutionize treatment options for various diseases.
Latest Patents
Jayesh holds a patent for "Single domain antibodies that bind to CD137." This patent relates to CD137 binding agents and their use in the treatment, prevention, and detection of disease. His innovative approach in this area showcases his commitment to advancing medical science.
Career Highlights
Jayesh is currently associated with Crescendo Biologics Limited, where he applies his expertise in antibody technology. His role at the company allows him to collaborate with other talented professionals in the field, further enhancing the impact of his work.
Collaborations
Some of his notable coworkers include Verena Brucklacher-Waldert and Carolyn Edwards. Their collective efforts contribute to the innovative environment at Crescendo Biologics Limited, fostering advancements in biotechnology.
Conclusion
Jayesh Majithiya is a key figure in the development of single domain antibodies, with a focus on CD137 binding agents. His contributions to the field of biotechnology are noteworthy, and his work continues to pave the way for future innovations in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile